Topic Hub
115 clinically reviewed articles, written and peer-reviewed by the HealthRX Medical Team.
Explore
Showing 115 of 115 clinical reviews.
A clinical guide to Anthem (Elevance Health) coverage for Evenity (romosozumab), including prior authorization criteria, step therapy requirements, formulary tier, appeal strategies, and cost-assistance options.
Read clinical reviewFind out whether Blue Cross Blue Shield federated plans cover Evenity (romosozumab) for osteoporosis, including prior authorization criteria, step therapy rules, formulary tier, appeal steps, and cost-saving options.
Read clinical reviewDetailed guide to Humana coverage of Evenity (romosozumab) for osteoporosis, including prior authorization criteria, formulary placement, step therapy rules, appeal pathways, and cost-saving options.
Read clinical reviewKaiser Permanente coverage policy for Evenity (romosozumab), including prior authorization criteria, formulary status, step therapy requirements, and how to appeal a denial.
Read clinical reviewFind out whether your state Medicaid program covers Evenity (romosozumab) for osteoporosis, what prior authorization criteria apply, and how to appeal a denial.
Read clinical reviewMedicare Advantage plans cover Evenity (romosozumab) under Part B for postmenopausal osteoporosis. Learn about prior authorization, step therapy, appeal options, and out-of-pocket costs.
Read clinical reviewTRICARE covers Evenity (romosozumab) for postmenopausal osteoporosis with prior authorization. Learn formulary tier, step therapy requirements, appeal process, and out-of-pocket costs for military beneficiaries.
Read clinical reviewClinical guidance on romosozumab (Evenity) use in adolescents aged 12-17, including off-label dosing considerations, safety data, and growth-related monitoring for severe pediatric osteoporosis.
Read clinical reviewEvidence-based monitoring guidance for romosozumab (Evenity) use in adolescents aged 12-17, covering bone biomarkers, cardiovascular screening, growth-plate surveillance, and mental-health checkpoints.
Read clinical reviewIs romosozumab (Evenity) safe for adolescents aged 12-17? Review of current evidence, FDA labeling gaps, cardiovascular warnings, skeletal maturity concerns, and what clinicians should consider before off-label use.
Read clinical reviewEvidence-based review of romosozumab (Evenity) drug-drug interactions, including cardiovascular risk modifiers, antiresorptives, and calcium-affecting medications, with PubMed-cited clinical data.
Read clinical reviewWhat Evenity (romosozumab) costs in Alaska in 2026, which insurance and Medicaid plans cover it, how the Amgen savings card works, and whether compounded romosozumab is available through 503A pharmacies.
Read clinical reviewEvenity (romosozumab) costs $1,825/month in Arizona in 2026. Learn about insurance coverage, Arizona Medicaid limitations, the Amgen savings card, and other ways to reduce your out-of-pocket cost.
Read clinical reviewWhat Evenity (romosozumab) costs in Arkansas in 2026, which insurance and Medicaid plans cover it, how the Amgen savings card works, and whether compounded romosozumab is available through 503A pharmacies.
Read clinical reviewCurrent Evenity (romosozumab) pricing in California for 2026, including Medi-Cal coverage, insurance options, manufacturer savings cards, and compounded alternatives.
Read clinical reviewWhat Evenity (romosozumab) costs in Colorado in 2026, which insurance plans cover it, how the Amgen savings card works, and what to know about Medicaid, telehealth, and compounding.
Read clinical reviewWhat Evenity (romosozumab) costs in Connecticut in 2026, which insurance and Medicaid plans cover it, how the Amgen savings card works, and whether compounded romosozumab is available through 503A pharmacies in the state.
Read clinical reviewCurrent Evenity (romosozumab) pricing in Delaware for 2026, including Medicaid coverage, insurance prior authorization requirements, the Amgen savings card, and 503A compounding pharmacy access.
Read clinical reviewWhat Evenity (romosozumab) costs in Georgia in 2026, which insurance plans cover it, Georgia Medicaid status, manufacturer savings cards, and how to lower your out-of-pocket price.
Read clinical reviewEvenity (romosozumab) costs about $1,825/month in Hawaii. Learn about insurance coverage, Hawaii Medicaid status, manufacturer savings cards, and how to lower your out-of-pocket cost.
Read clinical reviewComplete guide to Evenity (romosozumab) cost in Illinois for 2026, including Medicaid coverage, insurance options, manufacturer savings cards, and compounded alternatives.
Read clinical reviewEvenity (romosozumab) costs $1,825/month in Iowa at list price. Learn about Iowa Medicaid coverage, insurance options, the Amgen savings card, and how to lower your out-of-pocket cost for all 12 doses.
Read clinical reviewCurrent Evenity (romosozumab) pricing in Kansas for 2026, including insurance coverage details, Medicaid status, manufacturer savings programs, and telehealth access.
Read clinical reviewCurrent Evenity (romosozumab) pricing in Louisiana for 2026, including Medicaid coverage status, insurance options, the Amgen savings card, 503A compounding, and telehealth access.
Read clinical reviewCurrent Evenity (romosozumab) pricing in Maine for 2026, including cash-pay costs, Maine Medicaid coverage, insurance options, the Amgen savings card, and compounded alternatives.
Read clinical reviewCurrent 2026 pricing for Evenity (romosozumab) in Maryland, including Medicaid coverage, insurance options, the Amgen savings card, and 503A compounding availability.
Read clinical reviewCurrent Evenity (romosozumab) pricing in Massachusetts for 2026, including insurance coverage, Medicaid PA requirements, manufacturer savings cards, and 503A compounding options.
Read clinical reviewCurrent Evenity (romosozumab) pricing in Michigan for 2026, including Medicaid coverage, insurance options, the Amgen savings card, and how to reduce out-of-pocket costs for this bone-building osteoporosis treatment.
Read clinical reviewWhat Evenity (romosozumab) costs in Minnesota in 2026, including cash price, Medicaid coverage, insurance options, manufacturer savings cards, and 503A compounding access.
Read clinical reviewWhat Evenity (romosozumab) costs in Mississippi in 2026, which insurance plans cover it, how the Amgen savings card works, and whether compounded romosozumab is available through 503A pharmacies in the state.
Read clinical reviewCurrent Evenity (romosozumab) pricing in Missouri for 2026, including insurance coverage details, Medicaid status, manufacturer savings cards, and 503A compounding pharmacy access.
Read clinical reviewWhat Evenity (romosozumab) costs in Nebraska in 2026, including retail price, insurance coverage, Medicaid status, manufacturer savings cards, and 503A compounding options.
Read clinical reviewCurrent Evenity (romosozumab) pricing in Nevada for 2026, including cash-pay costs, Nevada Medicaid status, insurance coverage, manufacturer savings cards, and telehealth options.
Read clinical reviewCurrent Evenity (romosozumab) pricing in New Hampshire for 2026, including insurance coverage, Medicaid status, manufacturer savings cards, 503A compounding access, and telehealth options.
Read clinical reviewComplete guide to Evenity (romosozumab) cost in New Jersey for 2026, including Medicaid coverage, insurance options, manufacturer savings programs, and compounding pharmacy access.
Read clinical reviewCurrent Evenity (romosozumab) pricing in New Mexico for 2026, including cash-pay costs, insurance coverage details, Medicaid status, manufacturer savings programs, and cheaper alternatives.
Read clinical reviewCurrent Evenity (romosozumab) pricing in North Carolina for 2026, including insurance coverage, Medicaid status, manufacturer savings cards, 503A compounding options, and telehealth access.
Read clinical reviewEvenity (romosozumab) costs $1,825/month in North Dakota without insurance. Learn about Medicaid coverage, manufacturer savings cards, 503A compounding options, and how to reduce your out-of-pocket cost in ND.
Read clinical reviewCurrent Evenity (romosozumab) pricing in Ohio for 2026, including cash-pay costs, Ohio Medicaid coverage status, insurance prior authorization tips, the Amgen savings card, and 503A compounding legality.
Read clinical reviewWhat Evenity (romosozumab) costs in Oklahoma in 2026, which insurers cover it, how Oklahoma Medicaid handles it, and every discount path available to patients.
Read clinical reviewWhat Evenity (romosozumab) costs in Pennsylvania in 2026, which insurance and Medicaid plans cover it, how the Amgen savings card works, and whether compounded alternatives exist.
Read clinical reviewCurrent 2026 pricing for Evenity (romosozumab) in South Carolina, including cash-pay costs, Medicaid status, insurance coverage paths, the Amgen/UCB savings card, and 503A compounding options.
Read clinical reviewWhat Evenity (romosozumab) costs in Texas in 2026, which insurance and Medicaid plans cover it, how the Amgen/UCB savings card works, and whether compounded romosozumab is legal in the state.
Read clinical reviewCurrent Evenity (romosozumab) pricing in Utah for 2026, including cash-pay costs, Utah Medicaid coverage status, insurance options, manufacturer savings cards, and compounding pharmacy alternatives.
Read clinical reviewWhat Evenity (romosozumab) costs in Vermont in 2026, including cash price, Medicaid coverage, insurance options, the Amgen savings card, and 503A compounding availability.
Read clinical reviewWhat Evenity (romosozumab) costs in Virginia in 2026, which insurance and Medicaid plans cover it, how the Amgen savings card works, and whether compounded options are legal in VA.
Read clinical reviewCurrent Evenity (romosozumab) pricing in Washington state for 2026, including Medicaid coverage, insurance options, the Amgen savings card, and compounded alternatives.
Read clinical reviewCurrent Evenity (romosozumab) pricing in West Virginia for 2026, including Medicaid coverage status, insurance options, manufacturer savings cards, and 503A compounding availability.
Read clinical reviewCurrent Evenity (romosozumab) pricing in Wisconsin for 2026, including Medicaid coverage, insurance options, the Amgen/UCB savings card, and how to reduce your out-of-pocket cost.
Read clinical reviewCurrent pricing for Evenity (romosozumab) in Wyoming including insurance coverage, Medicaid status, 503A compounding options, telehealth access, and manufacturer savings programs for 2026.
Read clinical reviewEvidence-based guide to romosozumab (Evenity) dosing in patients with liver disease. Covers pharmacokinetics, FDA labeling gaps, clinical considerations, and monitoring for hepatic impairment.
Read clinical reviewEvidence-based guide to romosozumab (Evenity) dosing across all stages of kidney disease, including CKD-MBD considerations, hypocalcemia risk, and monitoring protocols.
Read clinical reviewEvidence-based guide to food and supplement interactions with romosozumab (Evenity), including calcium, vitamin D, magnesium, and cardiovascular considerations during the 12-month treatment course.
Read clinical reviewExpert analysis of romosozumab pipeline developments, next-generation sclerostin inhibitors, oral formulations under investigation, and what's ahead for bone-building therapy after Evenity.
Read clinical reviewEvidence-based guide to romosozumab (Evenity) dosing in adults 65 and older, covering standard 210 mg monthly protocol, renal considerations, cardiovascular screening, fall risk, and sequential therapy after 12 doses.
Read clinical reviewEvidence-based monitoring protocol for romosozumab (Evenity) in patients aged 65 and older, covering cardiovascular screening, bone density tracking, renal function, calcium levels, and transition therapy planning.
Read clinical reviewA clinical deep-dive into how Evenity (romosozumab) is manufactured, its biologics supply chain, and a documented timeline of FDA-tracked shortages since approval.
Read clinical reviewA physician-level deep dive into how romosozumab works, from sclerostin inhibition to dual anabolic-antiresorptive bone remodeling. Covers the Wnt signaling pathway, RANKL modulation, clinical trial evidence, and sequencing strategies.
Read clinical reviewEvidence-based guide to managing missed doses of Evenity (romosozumab), including clinical recommendations, bone-turnover marker recovery, and how delays affect fracture protection during the 12-month treatment window.
Read clinical reviewComplete monitoring guide for romosozumab (Evenity) in adults aged 50 to 64. Covers baseline labs, cardiovascular screening, bone turnover markers, calcium management, and month-by-month tracking across all 12 doses.
Read clinical reviewShowing the first 60 matches. Use search or filters to narrow the library.